5255 — Monstarlab Income Statement
0.000.00%
- ¥18bn
- ¥23bn
- ¥10bn
Annual income statement for Monstarlab, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,420 | 9,346 | 14,271 | 13,347 | 10,003 |
Cost of Revenue | |||||
Gross Profit | 2,148 | 2,928 | 4,945 | 3,340 | 1,425 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8,882 | 12,489 | 14,589 | 15,404 | 20,273 |
Operating Profit | -1,463 | -3,143 | -318 | -2,057 | -10,270 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,549 | -3,090 | -447 | -2,156 | -9,846 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,473 | -3,089 | -724 | -2,320 | -9,979 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1,274 | -3,053 | -675 | -2,355 | -9,948 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,274 | -3,053 | -675 | -2,355 | -9,948 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -25.4 | -46.3 | -16.8 | -85.5 | -157 |
Dividends per Share |